![Scott Giacobello](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Scott Giacobello
Finanzdirektor/CFO bei
WHITEHAWK THERAPEUTICS, INC.
Vermögen: 2 Mio $ am 30.06.2026
Profil
Scott M. Giacobello hat die Position des Chief Financial Officer & Head-Investor Relations bei GW Pharmaceuticals Plc inne. Herr Giacobello ist auch im Vorstand von Autobahn Therapeutics, Inc. Zuvor hatte er die Position des Chief Financial Officer von Chase Pharmaceuticals Corp. und VP-Global Research & Development Finance bei Allergan Plc. inne. Er erhielt einen Bachelor-Abschluss von der Notre Dame Academy.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 14.05.2026 | 333’489 ( 0.71% ) | 2 Mio $ | 30.06.2026 |
Aktive Positionen von Scott Giacobello
| Unternehmen | Position | Beginn |
|---|---|---|
| WHITEHAWK THERAPEUTICS, INC. | Finanzdirektor/CFO | 28.11.2021 |
Autobahn Therapeutics, Inc.
 Autobahn Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biotechnology company that develops medications for the treatment of central nervous system (CNS) disorders | Direktor/Vorstandsmitglied | 05.01.2021 |
Ehemalige bekannte Positionen von Scott Giacobello
| Unternehmen | Position | Ende |
|---|---|---|
| GW PHARMACEUTICALS PLC | Finanzdirektor/CFO | 01.05.2021 |
Chase Pharmaceuticals Corp.
 Chase Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Develops novel medications for the treatment of Alzheimer’s disease | Finanzdirektor/CFO | 01.11.2016 |
| ALLERGAN PLC | Finanzdirektor/CFO | - |
Goodwill Industries of Orange County, California
 Goodwill Industries of Orange County, California Miscellaneous Commercial ServicesCommercial Services Assists individuals with work and social abilities, cultural & language skills | Direktor/Vorstandsmitglied | - |
Ausbildung von Scott Giacobello
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
62
Beziehungen ersten Grades
7
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 7 |
|---|---|
Chase Pharmaceuticals Corp.
Chase Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Develops novel medications for the treatment of Alzheimer’s disease | Health Technology |
GW Pharmaceuticals Ltd.
 GW Pharmaceuticals Ltd. Miscellaneous Commercial ServicesCommercial Services Engages in development and commercialization of cannabinoid-based prescription medicines | Commercial Services |
Goodwill Industries of Orange County, California
Goodwill Industries of Orange County, California Miscellaneous Commercial ServicesCommercial Services Assists individuals with work and social abilities, cultural & language skills | Commercial Services |
Allergan Ltd. (Ireland)
 Allergan Ltd. (Ireland) Pharmaceuticals: MajorHealth Technology Develops, manufactures and commercializes pharmaceuticals, devices, biological, surgical & regenerative medicine products | Health Technology |
Notre Dame Academy
 Notre Dame Academy Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Autobahn Therapeutics, Inc.
Autobahn Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biotechnology company that develops medications for the treatment of central nervous system (CNS) disorders | Health Technology |
Aadi Bioscience, Inc.
 Aadi Bioscience, Inc. BiotechnologyHealth Technology Develops mTOR inhibitor for targeted patient populations in oncology and cardiovascular diseases | Health Technology |
